Professional Documents
Culture Documents
Aerobic,
slightly curved or straight rods Measures 0.2 to 0.4 x 2 to 10 Nonmotile Nonsporogenous, Nonencapsulated Most distinctive property ACID FASTNESS Some are saprophytes in soil, others are parasites 2 species causing 2 most dreaded diseases:
Some
Most
Cell wall contains N-glycolylmuramic acid in lieu of N-acetylmuramic acid and very high lipid content:
Contributes to acid fastness Difficult to stain with commonly used aniline dyes Unusual resistance to the effects of drying and harsh decontaminating agents
Hydrophobic cell surface makes these organisms grow more slowly (does not easily allows nutrients to enter the cell)
Have
important characteristics in common with Corynebacterium and Nocardia called CNM group produce mycolic acid and similar guanine-plus-cytosine (G+C) content
All
71
recognized or proposed species Divided into 2 MAJOR GROUPS based on fundamental differences in epidemiology and association with the disease:
Mycobacterium tuberculosis Complex Nontuberculous Mycobacteria (NTM)
Mycobacterial
include:
M. M. M. M.
All
ORGANISM M. tuberculosis
HABITAT
DISTRIBUTION Worldwide
Primary reservoir: inhalation of droplet nuclei patients with (infectious aerosols, 1-5, cavitary disease reach the lungs alveoli): Person to person contact Manipulation of lesions / clinical specimens in the lab Airborne transmission Humans Wide range of animals Humans Ingestion of contaminated milk from infection cows Airborne transmission Inhalation of droplet nuclei
M. bovis
Worldwide
M. Africanum
Slender,
Appear
May
Acid
fast (due to long chain of mycolic acid and physical integrity of the cell)
LIPID BARRIER PRINCIPLE: increased hydrophobicity of the surface layers follows the complexing of dye with mycolic acid residues present in cell wall > prevents exit of carbol fuchsin trapped in the cell
True
Obligate
aerobe Grow on ordinary simple synthetic medium, but for 1o isolation from clinical material, requires a more complex medium Grow very slowly: colonies seen in 2-3 weeks of incubation at 37oC on egg media but no growth at 25oC and 45oC Forms PELLICLE on surface of Liquid medium after 14-15 hours Eugonic Catalase (+) Niacin (+) Nitrate Reduction Test (+)
Solid Medium: DRY, FRIABLE, ROUGH, WATERY, GRANULAR, AND BUFF COLORED WITH A FLAT, IRREGULAR MARGIN AND A CAULIFLOWER CENTER
Highly
resistant to drying Cultures kept for 12 years at 37oC still viable and virulent When exposed to direct sunlight:
Organism from cultures killed in 2 hours Organisms in sputum killed in 20-30 hours
Bacilli
in dried sputum protected from sunlight: viable for 6-8 months More resistant to chemical agents Killed by pasteurization
No
Survival and growth inside monocytes and macrophages (inhibits phagolysosomal fusion) Resistant to many disinfectants
Mycolic
acids
Large (C60-C90), saturated, -alkyl, -hydroxyl fatty acids found in both waxes (esters of fatty acids with fatty alcohols) and glycolipids (lipid linked to carbohydrates).
Cord
Factor
Contributes to the virulence of M. tb strains a mycoside of 6,6'-dimycolate of trehalose (dimer of 1,1 linked glucose nonreducing sugar) contributes to the hydrophobic character of the organism Toxic - causes profound disturbances of microsomal enzymes, mitochondria, and lipid metabolism in the liver responsible for neutral red reactivity associated with virulent strains
Sulfatides
Lipoarabinomannan
CW glycolipid suppresses T cell proliferation may interfere with interferon-gamma secretion extracellular soluble compound that robs iron from ferritin (storage form of iron in the mammalian cell)
exochelin
mycobactins
cell associated and transport the iron through the mycobacterial cell wall
Causative
agent of Bovine Tuberculosis Infection occurs in humans s by consuming raw or un-pasteurized milk from TB infected cows.
Requires
longer period of incubation: 3-6 weeks at 35C Colony: TINY, TRANSLUSCENT, SMOOTH, PYRAMIDAL COLONIES
Dysgonic
Antigenic,
non-infectious Forms serpentine cords Niacin (-) Nitrate Reductase test (-) SUSCEPTIBLE to TCH (Thiopene-2-carboxylic acid Hydrazide)
Tuberculous
cervical lymphadenitis
Formerly called SCROFULA tuberculosis of the cervical lymph nodes condition characterized by enlarged, inflamed, and tender lymph nodes of the neck (seen in certain infectious diseases of children) Also called cervical adenitis
Mesenteric
Adenitis
condition clinically resembling acute appendicitis there is inflammation of the mesenteric lymph nodes receiving lymph from the intestine.
Tuberculosis
of the Bones
and Joints
encountered in any age group No bone is immune from involvement by TB The most common location in childhood is spine and the most frequently involved joints are the weight-bearing joints such as hip, knee, shoulders, or elbow
First
identified and reported as a separate sub-species of M. tuberculosis complex (MTBC) in 1968 Isolated from sputum samples of TB patients in Europe, the United States, and Africa Traditionally been identified by phenotypic criteria, occupying a position between M. bovis and M. tuberculosis according to biochemical characteristics Divided into M. africanum subtype I and M. africanum subtype II based on biochemical criteria
M. africanum subtype II has been identified as a major cause of human tuberculosis in Uganda
Live
attenuated bacillus vaccine derived from the closely related virulent strain of M. bovis for the prevention of Tuberculosis Developed by Calmette and Gurin at the Pasteur Institute of Lille in 1908
original virulent strain isolated from an infected cattle was grown for 13 years on potato slices cooked in beef bile supplemented by glycerol First human vaccination with this attenuated strain, named Bacille Calmette-Gurin (BCG), was applied in 1921 in Paris
Introduced
Freeze-dried
BCG vaccine
international name and proper name of manufactured BCG vaccine as recommended by WHO intended for intradermal injection Freeze-dried BCG vaccine, Percutaneous name of BCG vaccine intended for percutaneous vaccination Immunize susceptible individuals versus Tuberculosis Boost the nonspecific cellular immune response of certain immunologically deficient patients
Uses:
Includes
all other species that do not belong to M. tuberculosis Complex Initially considered as strictly saprophytes Ubiquitos a.k.a. as ATYPICAL Mycobacteria or MOTT Can produce severe and even fatal disease in humans through:
RUNYONs
CLASSIFICATION
Based on phenotypic and characteristics of the various species: GROWTH RATE and COLONIAL PIGMENTATION
NONCULTIVABLE
NTM
Mycobacterium leprae
NTM
GROUP NAME
DESCRIPTION
Colonies that develop pigment following exposure to light after being grown in the dark and take more than 7 days to appear on solid media Colonies that develop pigment in the dark or light and take more than 7 days to appear on solid media
PHOTOCHROMOGENS
II
SCOTOCHROMOGENS
III
IV
Colonies that are nonpigmented regardless of NONPHTOCHROMOGENS whether grown in the dark or light and take more than 7 days to appear on solid media RAPID GROWERS Colonies that appear on solid media in less than 7 days
synthesize
carotenoids (yellow to red pigment) in varying amounts Some are considered potentially pathogenic for humans, others are rarely associated with diseases. Divided into THREE groups:
ORGANISM
EPIDEMIOLOGY
PATHOGENICITY
TYPES OF INFECTION Chronic Pulmonary Diseases; Extrapulmonary Diseases (Cervical Lymphadenitis & Cutaneous Dss.) Pulmonary Disease
M. kansasii
Infection more common in white males. Natural reservoir is tap water Not commonly encountered
Potentially Pathogenic
M. asiaticum
Potentially Pathogenic
M. marinum
Natural reservoir is fresh water & saltwater as a result of contamination Potentially from infected fish & Pathogenic other marine life (entry by trauma or small breaks in skin) UNKNOWN UNKNOWN Potentially Pathogenic Potentially Pathogenic
Pulmonary Disease
M. intermedium M. movocastrense
Epidemiology
of the potentially pathogenic scotochromogens has not been definitevely described Organisms are rarely recovered in clinical laboratories
ORGANISM
EPIDEMIOLOGY
M. szulgai
M. scrofulaceum M. interjectum
M. heckeshornense UNKNOWN
M. tusciae M. gordonae M. cookii M. hiberniae UNKNOWN Tap water, soil Sphagnum, surface waters in NZ Sphagnum, soil in Ireland
M. kubicae
UNKNOWN
NonPathogenic
NA
Nonpathogenic
to humans
Others
are potentially pathogenic and many are frequently encountered in the clinical laboratory Mycobacterium avium complex
Frequently isolated in the clinical laboratory Able to cause infection in the human host
TYPES OF INFECTION Pulmonary infections in patients w/ preexisting pulmonary disease; Cervical lymphadenitis Disseminated disease in immunocompromised, HIVnegative patients,& patients w/ AIDS 1 Pulmonary infections in adults Less common: Extrapulmonary infections, & disseminated disease Indolent cutaneous and subcutaneous infections
M. xenopi
Water (especially hot water taps in hospitals); believed to be transmitted in aerosols Not isolated in the environment but infections occur in Tropical / temperate climates
M. ulcerans
ORGANISM M. malmoense
EPIDEMIOLOGY Majority of cases isolated from England, Wales, & Sweden Rarely isolated from patients with HIV Isolated only from humans & captured armadillos
TYPES OF INFECTION Chronic Pulmonary infections primarily in patients w/ preexisting pulmonary disease; Cervical lymphadenitis in children Less common infections of the skin or bursa
M. genavense
Isolated from pet birds and Disseminated disease in patients w/ dogs. Mode of acquisition is AIDS UNKNOWN
M. haemophilum
UNKNOWN
Disseminated disease Cutaneous infections in immunosuppressed adults Mild & limited skin infections in pre- or early adolescence Cervical lymphadenitis in children
Lymphadenitis in children Isolated from sputum, urine, and gastric aspirate
M. UNKNOWN heidelbergense
ORGANISM M. shimoidei
EPIDEMIOLOGY Not isolated from environmental sources Few case reports Widely spread geographically Not well delineated; rarely isolated
M. simiae
Comprised
of : M. avium, M. intracellulare, M. paratuberculosis, M. lepraemurium, M. silvaticum Pathogenic to humans: M. avium, M. intracellulare, M. paratuberculosis M. avium & M. intracellulare:
Closely resemble to each other Distinction cannot be made by routine laboratory determination / clinical grounds Referred to as M. avium-intracellulare
EPIDEMIOLOGY
and PATHOGENESIS
Ubiquitous in the environment Isolated from natural water, soil, dairy products, pigs, chickens, cats, and dogs Natural waters serve as the major reservoir for most human infections Infections acquired through inhalation or ingestion Pathogenesis of infection not clearly understood Most commonly isolated mycobacterial species in the United States:
High prevalence in individuals affected with HIV Approximately 90% of mycobacterial infections in patients with AIDS involve either MAC or Mtb
CULTURAL
CHARACTERISTICS
Exhibit OPAQUE and TRANSLUCENT/TRANSPARENT colony morphology Transparent colonies are more virulent:
More drug resistant Isolated more frequently from blood of patients with AIDS Appearing more virulent in macrophage and animal models
EPIDEMIOLOGY
and PATHOGENESIS
Causes Johnes Disease in cattle, sheep, and goats Isolated from the bowel mucosa of patients with Crohns Disease (chronic inflammatory bowel disease in humans)
CULTURAL
CHARACTERISTICS
Extremely fastidious Requires MYCOBACTIN (growth factor produced by other mycobacterial species, such as M. phlei) May take as long as 6-18 months for primary isolation
pathogenic rapidly growing mycobcateria are currently recognized Most species are purely environmental saprophytes Can grow on routine bacteriologic media, and on media specific for cultivation of mycobacteria Colonies appear in 72 hours of incubation at 37oC Appear as weakly gram-positive rods resembling diptheroids in Gram Staining
EPIDEMIOLOGY and PATHOGENESIS Ubiquitous in the environment & present worldwide Found in soil, marshes, rivers, municipal water
Community acquired from environmental sources Nosocomially acquired as a result of medical intervention Commensals of the skin
Chronic Pulmonary infections caused by rapidly growing NTM suggests a possible respiratory route for acquisition of organisms present in the environment No known 1o animal host but apparently exist in the soil No evidence of direct transmission of organisms from man to man
and PATHOGENESIS
from 2 coinciding events:
ORGANISM
M. abscessus
M. fortuitum
M. chelonae
M. fortuitum third biovariant complex sorbitol (+/-)
M. peregrinum M. mucogenicum
M. smegmatis
Skin and soft tissue infections Posttraumatic wound infections, catheter-related sepsis
Skin or soft tissue infections
Most
Usually
M.
marinum M. ulcerans
M.
NON-CULTIVABLE MYCOBACTERIUM
An
ancient disease HANSENs Disease Chronic disease of the skin, mucous membranes, and nerve tissues A disease that continues to threaten the quality of life of more than 12 million people world wide. With increase in population and rapid means of transportation, there is increased contact between susceptible travelers and millions of patients who have leprosy.
Cannot
Grown
Difficult
to propagate and transmit to experimental animals. Slow growth in both animals and in patients An obligate intracellular parasite that multiplies very slowly within the mononuclear phagocytes, especially the histiocytes of the skin and Schwann cells of the nerves
Most
prevalent in Tropical countries Primary reservoir is infected humans Infectivity is very low Transmission of Leprosy (Person to Person):
Infection thru contact with patients with Lepromatous Leprosy who shed organisms in nasal secretions. Prolonged close contact
Major
portal of entry: respiratory tract Potential source of infection: insect bites and breast milk Cutaneous route thru excoriations no significant role
Spectrum
TUBERCULOID
LEPROSY (TT)
Disease is localized to the skin and nerves No immune defect Few organisms in skin lesions
LEPROMATOUS
LEPROSY (LL)
Disseminated form Defect in Cell Mediated Immunity (CMI) Patient is anergic to M. leprae Bacterial growth is impeded Extensive skin lesions containing numerous bacilli
Borderline
tuberculoid leprosy (BT) Borderline leprosy (BB) Borderline lepromatous leprosy (BL)
Long
of patients has solitary lesion and heal spontaneously Disease progress from 1 form to form to another
Immunologic
prognosis:
most severe and extensive form of disease Leonine facies (deeply furrowed lumpy face with prominent superciliary arches) Trauma Secondary infection
Hansen
in 1874 described the myriads of bacilli in the lesions of leprosy patients. Acid fast in modified mononuclear or epitheloid cells called lepra cells arranged like packets of cigars.
Organisms
Bacilli
are usually straight or curved and may stain uniformly or show granular beads.
Uniformly stained bacilli are healthy bacilli Beaded bacilli are probably non viable
Footpads
of normal mice are injected with materials from leprosy patients In mouse, infection can be initiated with as low as 1-10 bacilli Footpad temperature is 30C
Generation
time is 12 days
Multiplication
continues for 150-180 days until number of bacilli reaches 1 X 106 bacteria. Multiplication stops because of CMI. Used for drug screening and vaccination experiments
Nine-banded
armadillos is used Armadillos has disseminated leprosy Used to study immunologic factors that control development of disease Provide large numbers of M. leprae for vaccination study
POLYMERASE
Suspect
leprosy
Demonstration
Ziehl Neelsen Method Cold Kinyoun Technique Wade-Fite Technique used in paraffinized tissue and demonstration of AFB in tissue secretions
LEPROMIN
TEST
Not diagnostically useful of value in determining the position of the patient on the immunologic spectrum Lepromin - suspension of heat killed M. leprae Detects for:
Early reaction Fernandez reaction Late reaction Mitsuda reaction Tuberculoid Leprosy: (+) for Early and Late Reactions Lepromatous Leprosy: (-) for Early and Late Reactions Lacks specificity Causes False (+): persons with Tuberculosis healthy children with BCG vaccine
Results:
Disadvantages: